{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:35:07Z","timestamp":1790606107260,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In clinical settings, pulmonary tuberculosis (PTB) patients were often found to have pulmonary fungal coinfection. This study aimed to assess the clinical characteristics of patients suffering from coinfection with TB and pulmonary fungal and construct a predictive model for evaluating the probability of pulmonary fungal coinfection in patients with pulmonary tuberculosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The present case\u2013control study retrospectively collected information from 286 patients affected by PTB who received treatment from December 6,2016- December 6,2021 at Beijing Chest Hospital, Capital Medical University. As control subjects, patients with sex and address corresponding to those of the case subjects were included in the study in a ratio of 1:1. These 286 patients were randomly divided into the training and internal validation sets in a ratio of 3:1. Chi-square test and logistic regression analysis were performed for the training set, and a predictive model was developed using the selected predictors. Bootstrapping was performed for internal validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seven variables [illness course, pulmonary cavitation, broad-spectrum antibiotics use for at least 1\u00a0week, chemotherapy or immunosuppressants, surgery, bacterial pneumonia, and hypoproteinemia] were validated and used to develop a predictive model which showed good discrimination capability for both training set [area under the curve (AUC)\u2009=\u20090.860, 95% confidence interval (CI)\u2009=\u20090.811\u20130.909] and internal validation set (AUC\u2009=\u20090.884, 95% CI\u2009=\u20090.799\u20130.970). The calibration curves also showed that the probabilities predicted using the predictive model had satisfactory consistency with the actual probability for both training and internal validation sets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We developed a predictive model that can predict the probability of pulmonary fungal coinfection in pulmonary tuberculosis patients. It showed potential clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02344-4","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:02:56Z","timestamp":1675728176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical characteristics and predictive model of pulmonary tuberculosis patients with pulmonary fungal coinfection"],"prefix":"10.1186","volume":"23","author":[{"given":"Hongxuan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangchao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"issue":"suppl6","key":"2344_CR1","doi-asserted-by":"publisher","first-page":"S636","DOI":"10.1093\/infdis\/jix361","volume":"216","author":"RD Turner","year":"2017","unstructured":"Turner RD, Chiu C, Churchyard GJ, et al. Tuberculosis infectiousness and host susceptibility. J Infect Dis. 2017;216(suppl6):S636\u201343. https:\/\/doi.org\/10.1093\/infdis\/jix361.","journal-title":"J Infect Dis"},{"key":"2344_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30079-6","author":"K Dheda","year":"2017","unstructured":"Dheda K, Gumbo T, Maartens G, et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med. 2017. https:\/\/doi.org\/10.1016\/S2213-2600(17)30079-6.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2344_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12879-016-2151-5","volume":"17","author":"P Ding","year":"2017","unstructured":"Ding P, Li X, Jia Z, et al. Multidrug-resistant tuberculosis (MDR-TB) disease burden in China: a systematic review and spatio-temporal analysis. BMC Infect Dis. 2017;17(1):57. https:\/\/doi.org\/10.1186\/s12879-016-2151-5.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"2344_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0255-0857(21)03246-1","volume":"20","author":"AM Kurhade","year":"2002","unstructured":"Kurhade AM, Deshmukh JM, Fule RP, et al. Mycological and serological study of pulmonary aspergillosis in central India. Indian J Med Microbiol. 2002;20(3):141\u20134.","journal-title":"Indian J Med Microbiol"},{"issue":"2","key":"2344_CR5","first-page":"117","volume":"26","author":"O Ekenna","year":"2007","unstructured":"Ekenna O, Uba A, Chikwem JO, Mambula S, Aliyu MB, Mohammed I. Relevance of moldy fungi as agents of chronic lower respiratory tract infection in patients seen in Maiduguri, Nigeria. West African J Med. 2007;26(2):117\u201320.","journal-title":"West African J Med"},{"issue":"6","key":"2344_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4314\/ejhs.v28i6.2","volume":"28","author":"MRJ Amiri","year":"2018","unstructured":"Amiri MRJ, Siami R, Khaledi A. Tuberculosis status and coinfection of pulmonary fungal infections in patients referred to reference laboratory of health centers Ghaemshahr City during 2007\u20132017. Ethiop J Health Sci. 2018;28(6):683\u201390. https:\/\/doi.org\/10.4314\/ejhs.v28i6.2.","journal-title":"Ethiop J Health Sci"},{"issue":"8","key":"2344_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.4066\/AMJ.2013.1709","volume":"6","author":"A Kali","year":"2013","unstructured":"Kali A, Charles MP, Noyal MJ, et al. Prevalence of Candida co-infection in patients with pulmonary tuberculosis. Australas Med J. 2013;6(8):387\u201391. https:\/\/doi.org\/10.4066\/AMJ.2013.1709.","journal-title":"Australas Med J"},{"issue":"1","key":"2344_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20(1):133\u201363. https:\/\/doi.org\/10.1128\/CMR.00029-06.","journal-title":"Clin Microbiol Rev"},{"key":"2344_CR9","first-page":"857","volume":"36","author":"SA Naz","year":"2004","unstructured":"Naz SA, Tariq P. A study of the trend in prevalence of opportunistic Candidal coinfections among patients of pulmonary tuberculosis. Pak J Bot. 2004;36:857\u201362.","journal-title":"Pak J Bot"},{"key":"2344_CR10","doi-asserted-by":"publisher","first-page":"103898","DOI":"10.1016\/j.micpath.2019.103898","volume":"139","author":"M Hadadi-Fishani","year":"2020","unstructured":"Hadadi-Fishani M, Shakerimoghaddam A, Khaledi A. Candida coinfection among patients with pulmonary tuberculosis in Asia and Africa; a systematic review and meta-analysis of cross-sectional studies. Microb Pathog. 2020;139:103898. https:\/\/doi.org\/10.1016\/j.micpath.2019.103898.","journal-title":"Microb Pathog"},{"issue":"4","key":"2344_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jtcvs.2014.02.064","volume":"148","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Sun Y, Xiang J, et al. A clinicopathologic prediction model for postoperative recurrence in stage Ia non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014;148(4):1193\u20139. https:\/\/doi.org\/10.1016\/j.jtcvs.2014.02.064.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"2344_CR12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1200\/JCO.2014.56.6661","volume":"33","author":"W Liang","year":"2015","unstructured":"Liang W, Zhang L, Jiang G, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015;33(8):861\u20139. https:\/\/doi.org\/10.1200\/JCO.2014.56.6661.","journal-title":"J Clin Oncol"},{"key":"2344_CR13","unstructured":"Health industry standard of the People's Republic of China-Tuberculosis Diagnosis (WS288\u20132017)"},{"key":"2344_CR14","unstructured":"Chinese medical society of respiratory society, Chinese editorial board of tuberculosis and respiratory journal. Pulmonary mycosis diagnosis and treatment expert consensus. The Chinese Journal of Tuberculosis and Breath, 2007,30 (11): 821\u2013834"},{"key":"2344_CR15","first-page":"294","volume":"02","author":"G Ying","year":"2019","unstructured":"Ying G, Huazhen He, Zheng S. Clinical characteristics and risk factors of pulmonary tuberculosis complicated with pulmonary fungal infection [J]. Chin J Gerontol. 2019;02:294\u20137.","journal-title":"Chin J Gerontol"},{"issue":"8","key":"2344_CR16","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.26355\/eurrev_202204_28599","volume":"26","author":"GL Teng","year":"2022","unstructured":"Teng GL, Huang Q, Xu L, Chi JY, et al. Clinical features and risk factors of pulmonary tuberculosis complicated with pulmonary aspergillosis. Eur Rev Med Pharmacol Sci. 2022;26(8):2692\u2013701. https:\/\/doi.org\/10.26355\/eurrev_202204_28599.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2344_CR17","first-page":"906","volume":"08","author":"H Guojun","year":"2021","unstructured":"Guojun H, Xiao G, Xiliang T, et al. A meta-analysis of risk factors for pulmonary fungal infection. Pract Prevent Med. 2021;08:906\u201310.","journal-title":"Pract Prevent Med"},{"key":"2344_CR18","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1136\/bmj.g7594","volume":"350","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594. https:\/\/doi.org\/10.1136\/bmj.g7594.","journal-title":"BMJ"},{"issue":"3","key":"2344_CR19","doi-asserted-by":"publisher","first-page":"e0120201","DOI":"10.1371\/journal.pone.0120201","volume":"10","author":"MA Assis-Marques","year":"2015","unstructured":"Assis-Marques MA, Oliveira AF, Ruas LP, et al. Saccharomyces cerevisiae expressing Gp43 protects mice against Paracoccidioides brasiliensis infection. PLoS ONE. 2015;10(3):e0120201. https:\/\/doi.org\/10.1371\/journal.pone.0120201.","journal-title":"PLoS ONE"},{"issue":"1","key":"2344_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000371541","volume":"9","author":"LE Barrera-Herrera","year":"2015","unstructured":"Barrera-Herrera LE, Vera A, \u00c1lvarez J, et al. Necrotizing encephalitis caused by disseminated Aspergillus infection after orthotopic liver transplantation. Case Rep Gastroenterol. 2015;9(1):1\u20136. https:\/\/doi.org\/10.1159\/000371541.","journal-title":"Case Rep Gastroenterol"},{"issue":"9","key":"2344_CR21","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1128\/JB.00935-15","volume":"198","author":"K Flentie","year":"2016","unstructured":"Flentie K, Garner AL, Stallings CL. Mycobacterium tuberculosis transcription machinery: ready to respond to host attacks. J Bacteriol. 2016;198(9):1360\u201373. https:\/\/doi.org\/10.1128\/JB.00935-15.","journal-title":"J Bacteriol"},{"issue":"3","key":"2344_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000443360","volume":"34","author":"K Lange","year":"2016","unstructured":"Lange K, Buerger M, Stallmach A, et al. Effects of antibiotics on gut microbiota. Dig Dis. 2016;34(3):260\u20138. https:\/\/doi.org\/10.1159\/000443360.","journal-title":"Dig Dis"},{"issue":"2","key":"2344_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00281-015-0522-4","volume":"38","author":"AH Meijer","year":"2016","unstructured":"Meijer AH. Protection and pathology in TB: learning from the zebrafish model. Semin Immunopathol. 2016;38(2):261\u201373. https:\/\/doi.org\/10.1007\/s00281-015-0522-4.","journal-title":"Semin Immunopathol"},{"issue":"3","key":"2344_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1128\/CMR.00113-16","volume":"30","author":"ML Durand","year":"2017","unstructured":"Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3):597\u2013613. https:\/\/doi.org\/10.1128\/CMR.00113-16.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"2344_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.25100\/cm.v47i2.2271","volume":"47","author":"DM Fontalvo","year":"2016","unstructured":"Fontalvo DM, Jim\u00e9nez Borr\u00e9 G, G\u00f3mez Camargo D, et al. Tuberculosis and pulmonary candidiasis co-infection present in a previously healthy patient. Colomb Med (Cali). 2016;47(2):105\u20138.","journal-title":"Colomb Med (Cali)"},{"key":"2344_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1196\/annals.1321.010","volume":"1024","author":"IJ Elenkov","year":"2004","unstructured":"Elenkov IJ. Glucocorticoids and the Th1\/Th2 balance. Ann N Y Acad Sci. 2004;1024:138\u201346. https:\/\/doi.org\/10.1196\/annals.1321.010.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2344_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejcdt.2013.02.002","volume":"62","author":"NM Osman","year":"2013","unstructured":"Osman NM, Gomaa AA, Sayed NM. Microarray detection of fungal infection in pulmonary tuberculosis. Egypt J Chest Diseases Tuberculosis. 2013;62(1):151\u20137.","journal-title":"Egypt J Chest Diseases Tuberculosis."},{"issue":"5","key":"2344_CR28","first-page":"323","volume":"4","author":"VS Rathod","year":"2012","unstructured":"Rathod VS, Contr RJSE, Karuppayil SM. Antifungal drug susceptibility of Candida albicans isolates from tuberculosis patients. Int J Pharm Pharm Sci. 2012;4(5):323\u20136.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"3","key":"2344_CR29","doi-asserted-by":"publisher","first-page":"1801184","DOI":"10.1183\/13993003.01184-2018","volume":"53","author":"ID Page","year":"2019","unstructured":"Page ID, Byanyima R, Hosmane S, et al. Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual\u00a0cavitation. Eur Respir J. 2019;53(3):1801184. https:\/\/doi.org\/10.1183\/13993003.01184-2018.","journal-title":"Eur Respir J"},{"issue":"3","key":"2344_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4314\/ejhs.v28i3.7","volume":"28","author":"A Tavanaee Sani","year":"2018","unstructured":"Tavanaee Sani A, Ashna H, Kaffash A, et al. Mutations of rpob Gene associated with Rifampin resistance among Mycobacterium tuberculosis isolated in tuberculosis regional reference laboratory in Northeast of Iran during 2015\u20132016. Ethiop J Health Sci. 2018;28(3):299\u2013304. https:\/\/doi.org\/10.4314\/ejhs.v28i3.7.","journal-title":"Ethiop J Health Sci"},{"key":"2344_CR31","first-page":"52","volume":"51","author":"VP Baradkar","year":"2009","unstructured":"Baradkar VP, Mathur M, Wanjari K, et al. Candida in pulmonary tuberculosis. Bombay Hosp J. 2009;51:52\u20133.","journal-title":"Bombay Hosp J"},{"issue":"2","key":"2344_CR32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10156-012-0473-9","volume":"19","author":"H Hagiya","year":"2013","unstructured":"Hagiya H, Miyake T, Kokumai Y, et al. Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy. J Infect Chemother. 2013;19(2):342\u20137. https:\/\/doi.org\/10.1007\/s10156-012-0473-9.","journal-title":"J Infect Chemother"},{"issue":"3","key":"2344_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1183\/09031936.00226911","volume":"41","author":"DW Denning","year":"2012","unstructured":"Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis complicating sarcoidosis. European Respir J. 2012;41(3):621\u20136.","journal-title":"European Respir J"},{"key":"2344_CR34","doi-asserted-by":"publisher","first-page":"104018","DOI":"10.1016\/j.micpath.2020.104018","volume":"141","author":"M Hosseini","year":"2020","unstructured":"Hosseini M, Shakerimoghaddam A, Ghazalibina M, et al. Aspergillus coinfection among patients with pulmonary tuberculosis in Asia and Africa countries; a systematic review and meta-analysis of cross-sectional studies. Microb Pathog. 2020;141:104018. https:\/\/doi.org\/10.1016\/j.micpath.2020.104018.","journal-title":"Microb Pathog"},{"issue":"1","key":"2344_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00004728-200401000-00002","volume":"28","author":"T Franquet","year":"2004","unstructured":"Franquet T, M\u00fcller NL, Oikonomou A, et al. Aspergillus infection of the airways: computed tomography and pathologic findings. J Comput Assist Tomogr. 2004;28(1):10\u20136. https:\/\/doi.org\/10.1097\/00004728-200401000-00002.","journal-title":"J Comput Assist Tomogr"},{"key":"2344_CR36","unstructured":"Ogba O. International Journal of Innovative Medicine and Health Science PREVALENCE OF SYMPTOMATIC OPPORTUNISTIC RESPIRATORY MYCOSES AND MYCOBACTERIUM TUBERCULOSIS AMONG HUMAN IMMUNODEFICIENCY VIRUS POSITIVE PATIENTS IN CALABAR, NIGERIA. 2013."},{"issue":"3","key":"2344_CR37","first-page":"118","volume":"4","author":"S Mathavi","year":"2014","unstructured":"Mathavi S, Shankar R, Kavitha A, et al. A study on prevalence of pulmonary candidiasis among tuberculosis patients and use of chromagar in identification of candida species. J Drug Deliv Therapeutics. 2014;4(3):118\u201321.","journal-title":"J Drug Deliv Therapeutics"},{"issue":"6","key":"2344_CR38","doi-asserted-by":"publisher","first-page":"e479","DOI":"10.1016\/j.ijid.2009.07.011","volume":"14","author":"HS Nam","year":"2010","unstructured":"Nam HS, Jeon K, Um SW, et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis. 2010;14(6):e479\u201382. https:\/\/doi.org\/10.1016\/j.ijid.2009.07.011.","journal-title":"Int J Infect Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02344-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02344-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:04:30Z","timestamp":1675728270000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02344-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2344"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02344-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1993043\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"24 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Beijing Chest Hospital of the Capital Medical University (No.YJS-2021-039) and the study was conducted in accordance with the Helsinki Declaration. The requirement for written informed consent was waived by the Ethics Committee of Beijing Chest Hospital of the Capital Medical University based on the retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}